| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/19/2009 | WO2008151023A3 Methods and compositions for multiple displacement amplification of nucleic acids |
| 02/19/2009 | WO2008150463A3 Use of genetically modified organisms to generate biomass degrading enzymes |
| 02/19/2009 | WO2008145401A3 Mutated parvovirus structural proteins as vaccines |
| 02/19/2009 | WO2008143630A3 Recombinant hydrogen-producing cyanobacterium and uses thereof |
| 02/19/2009 | WO2008142036A3 Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-ko |
| 02/19/2009 | WO2008136670A3 Improved methods and means for lentiviral gene delivery |
| 02/19/2009 | WO2008129060A3 Plant produtivity enhancement by combining chemical agents with transgenic modifications |
| 02/19/2009 | WO2008127382A3 Computational design of ribozymes |
| 02/19/2009 | WO2008115958A3 Materials and methods for efficient succinate and malate production |
| 02/19/2009 | WO2008109547A4 Nucleic acid compounds for inhibiting tymp gene expression and uses thereof |
| 02/19/2009 | WO2008109506A9 Nucleic acid compounds for inhibiting jun gene expression and uses thereof |
| 02/19/2009 | WO2008109450A9 Nucleic acid compounds for inhibiting id-1 gene expression and uses thereof |
| 02/19/2009 | WO2008109443A4 Nucleic acid compounds for inhibiting cdk2 gene expression and uses thereof |
| 02/19/2009 | WO2008109352A4 Nucleic acid compounds for inhibiting akt gene expression and uses thereof |
| 02/19/2009 | WO2008109350A3 Nucleic acid compounds for inhibiting il6 gene expression and uses thereof |
| 02/19/2009 | WO2008101671A9 Il-4 fc fusion proteins |
| 02/19/2009 | WO2008088422A3 Toxin peptide therapeutic agents |
| 02/19/2009 | WO2008086529A3 Compositions and methods for targeted inactivation of hiv cell surface receptors |
| 02/19/2009 | WO2008073615A4 N-glycosylation mutant of melanoma differentiation associated gene-7 |
| 02/19/2009 | WO2008061537A3 Oligonucleotides for modulating target rna activity |
| 02/19/2009 | WO2007084585A3 Non-human primate embryonic stem and germ cells: methods of use and methods of making same |
| 02/19/2009 | WO2006112869A3 Modulation of cytokine signaling regulators and applications for immunotherapy |
| 02/19/2009 | WO2006052914A3 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 02/19/2009 | WO2005117569A3 A method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants and plants produced therefrom |
| 02/19/2009 | US20090049574 Use in altering root development, screening for herbicides; may enhance food production, especially in arid climates |
| 02/19/2009 | US20090049573 Transgenic plants with enhanced agronomic traits |
| 02/19/2009 | US20090049572 Elevation of oil levels in plants |
| 02/19/2009 | US20090049571 for regulating expression of nucleotide sequences in a plant; for a tissue preferred promoter isolated from the sorghum alpha -kafirin coding region or from the sorghum beta -kafirin coding region; drive expression preferentially to endosperm tissue |
| 02/19/2009 | US20090049570 Seed-Preferred Regulatory Elements |
| 02/19/2009 | US20090049569 Seed-Preferred Regulatory Elements |
| 02/19/2009 | US20090049568 Method for preventing dehiscence and altering plant lignification |
| 02/19/2009 | US20090049567 Transformation of soybean |
| 02/19/2009 | US20090049566 Expression vector for transcription factor polynucleotides; transgenic plants having increased soluble solids, lycopene, and improved plant volume or yield, increased anthocyanin in leaves, seedling vigor |
| 02/19/2009 | US20090049565 Methods to Identify Soybean Aphid Resistant Quantitative Trait Loci in Soybean and Compositions Thereof |
| 02/19/2009 | US20090049564 Cotton variety 02t15 |
| 02/19/2009 | US20090049563 Using cytosine deaminases to diminish retroelement transfer from pigs to humans |
| 02/19/2009 | US20090049562 Porcine cmp-n-acetylneuraminic acid hydroxylase gene |
| 02/19/2009 | US20090049561 Non-human animal exhibiting bone metastasis of tumor cells |
| 02/19/2009 | US20090048435 Oligonucleotide modulation of cell adhesion |
| 02/19/2009 | US20090048434 Compositions and methods relating to orthogonal ribosome mRNA pairs |
| 02/19/2009 | US20090048431 Multivalent clostridial toxins |
| 02/19/2009 | US20090048427 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 02/19/2009 | US20090048324 Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090048198 Compositions and methods for nucleic acid delivery systems |
| 02/19/2009 | US20090048196 Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions |
| 02/19/2009 | US20090048195 Compositions and methods of sphingosine kinase inhibitors for use thereof in cancer therapy |
| 02/19/2009 | US20090048191 Therapeutic molecules for modulating stability of vegf |
| 02/19/2009 | US20090048178 Lps or lipid a binding agent and novel peptide |
| 02/19/2009 | US20090048170 Target for anti-angiogenesis therapy |
| 02/19/2009 | US20090048169 Identification of Crmp4 as a Convergent Regulator of Axon Outgrowth Inhibition |
| 02/19/2009 | US20090048163 Nucleic acid and protein sequences of asporins |
| 02/19/2009 | US20090048161 Cytokine receptor modulators and uses thereof |
| 02/19/2009 | US20090048160 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (BPI)-derived peptides against Gram-negative bacterial mastitis isolates |
| 02/19/2009 | US20090048148 Compositions and methods for therapeutic use |
| 02/19/2009 | US20090048146 Use of agents that upregulate crystallin expression in the retina and optic nerve head |
| 02/19/2009 | US20090048136 Kappa-carrageenase and kappa-carrageenase-containing compositions |
| 02/19/2009 | US20090048124 Methods of amplifying and sequencing nucleic acids |
| 02/19/2009 | US20090048122 Stabilized polypeptide compositions |
| 02/19/2009 | US20090048111 Rna interference using a universal target |
| 02/19/2009 | US20090047742 Inhibition of mRNA Interferase-Induced Apoptosis in BAK-Deficient and BAK- and Bax-Deficient Mammalian Cells |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047737 Human LY6-Big Molecules and Methods of Use |
| 02/19/2009 | US20090047736 Human T1R2 nucleic acid sequences and polypeptides |
| 02/19/2009 | US20090047734 Method of separation of deoxyribonucleic acids |
| 02/19/2009 | US20090047733 Avidin-Pseudotyped Viral Vectors and Their Use |
| 02/19/2009 | US20090047728 Adenoviral vectors for influenza virus production |
| 02/19/2009 | US20090047710 ST3Gal-1/ST6GalNAc-1 Chimeras |
| 02/19/2009 | US20090047709 Novel endoribonuclease |
| 02/19/2009 | US20090047707 Bacterial recombinant phytase |
| 02/19/2009 | US20090047706 Process for producing dipeptides |
| 02/19/2009 | US20090047672 Telomerase RNA Subunit and Methods of Use Thereof |
| 02/19/2009 | US20090047671 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 02/19/2009 | US20090047668 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 02/19/2009 | US20090047661 Quantitative hiv phenotype or tropism assay |
| 02/19/2009 | US20090047387 Protease variants |
| 02/19/2009 | US20090047384 Lipolytic enzyme variants |
| 02/19/2009 | US20090047381 Ammonia transporter gene and use thereof |
| 02/19/2009 | US20090047380 Catalase gene and use thereof |
| 02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/19/2009 | US20090047302 Chimaeric Human Papillomavirus 16 L1 Virus Like Particles and a Method for Preparing the Particles |
| 02/19/2009 | US20090047286 H2n3 influenza a viruses and methods of use |
| 02/19/2009 | US20090047285 Compositions and methods for diagnosing and treating cancer |
| 02/19/2009 | US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/19/2009 | US20090047275 Modulating calvarial osteoblast differentiation; fracture repair |
| 02/19/2009 | US20090047273 Method For Production of Recombinant Human Thrombin ['644] |
| 02/19/2009 | US20090047271 Stable recombinant adenosine deaminase |
| 02/19/2009 | US20090047269 Metabolomic cancer targets |
| 02/19/2009 | US20090047262 Expression of class II transactivator fusion proteins for control of tumor growth |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | US20090047211 Anti-mesothelin antibodies useful for immunological assays |
| 02/19/2009 | CA2735575A1 Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system |
| 02/19/2009 | CA2733676A1 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 02/19/2009 | CA2722304A1 Immunoglobulins directed to bacterial, viral and endogeneous polypeptides |
| 02/19/2009 | CA2700923A1 Novel targets and compounds for therapeutic intervention of hiv infection |
| 02/19/2009 | CA2697265A1 Method of treating autoimmune disease with mesenchymal stem cells |
| 02/19/2009 | CA2696630A1 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 02/19/2009 | CA2696497A1 Tetrahydropyran nucleic acid analogs |
| 02/19/2009 | CA2696460A1 Combination motif immune stimulatory oligonucleotides with improved activity |
| 02/19/2009 | CA2696360A1 Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof |